Mucosal Tolerance and Immunity: Regulating the Development of Allergic Disease and Asthma (original) (raw)
Article navigation
Review Articles| March 26 2003
Division of Immunology and Allergy, Department of Pediatrics, Stanford University, Stanford, Calif., USA
Search for other works by this author on:
Division of Immunology and Allergy, Department of Pediatrics, Stanford University, Stanford, Calif., USA
Search for other works by this author on:
Division of Immunology and Allergy, Department of Pediatrics, Stanford University, Stanford, Calif., USA
Search for other works by this author on:
Division of Immunology and Allergy, Department of Pediatrics, Stanford University, Stanford, Calif., USA
Search for other works by this author on:
Int Arch Allergy Immunol (2003) 130 (2): 108–118.
Abstract
Allergic diseases and asthma are characterized by eosinophilic inflammation induced by Th2 lymphocytes. However, the immunological events and the molecular and cellular mechanisms that protect against and regulate these pathological immune responses are poorly understood. In this review, we discuss the role of immunological tolerance, regulatory T cells, and dendritic cells (DCs) in these protective processes. In addition, we discuss factors like the maturation state of DCs, source and effect of Il-10 production as well as specific combinations of costimulatory molecules in the antigen-presenting cell: T cell synapse, which determine whether tolerance or immunity develops in the respiratory mucosa in response to inhaled allergen.
References
Goldsby RA, Kindt TJ, Osborne BA: Immunology, 4 ed. New York, Freeman; 2000.
Chen Y, Inobe J, Marks R, Gonnella P, Kuchroo VK, Weiner HL: Peripheral deletion of antigen-reactive T cells in oral tolerance. Nature 1995;376:177–180.
Chen Y, Kuchroo VK, Inobe J, Hafler DA, Weiner HL: Regulatory T cell clones induced by oral tolerance: Suppression of autoimmune encephalomyelitis. Science 1994;265:1237–1240.
Hansen G, McIntire JJ, Yeung VP, Berry G, Thorbecke GJ, Chen L, et al: CD4+ Th cells engineered to produce latent TGF-β1 reverse allergen-induced airway hyperreactivity and inflammation. J Clin Invest 2000;11:89–96.
Sporik R, Holgate ST, Platts-Mills TA, Cogswell JJ: Exposure to house-dust mite allergen (Der p I) and the development of asthma in childhood. A prospective study. N Engl J Med 1990;323:502–507.
O’Hollaren MT, Yunginger JW, Offord KP, Somers MJ, O’Connell EJ, Ballard DJ, et al: Exposure to an aeroallergen as a possible precipitating factor in respiratory arrest in young patients with asthma. N Engl J Med 1991;324:359–363.
Burrows B, Martinez FD, Halonen M, Barbee RA, Cline MG: Association of asthma with serum IgE levels and skin-test reactivity to allergens. N Engl J Med 1989;320:271.
Sears MR, Burrows B, Flannery EM, Herbison GP, Hewitt CJ, Holdaway MD: Relation between airway responsiveness and serum IgE in children with asthma and in apparently normal children. N Engl J Med 1991;325:1067–1071.
Steinman RM: The dendritic cell system and its role in immunogenicity. Annu Rev Immunol 1991;9:271–296.
Xia W, Pinto CE, Kradin RL: The antigen-presenting activities of Ia+ dendritic cells shift dynamically from lung to lymph node after an airway challenge with soluble antigen. J Exp Med 1995;181:1275–1283.
Nelson DJ, McMenamin C, McWilliam AS, Brenan M, Holt PG: Development of the airway intraepithelial dendritic cell network in the rat from class II major histocompatibility (Ia)-negative precursors: Differential regulation of Ia expression at different levels of the respiratory tract. J Exp Med 1994;179:203–212.
McWilliam AS, Nelson D, Thomas JA, Holt PG: Rapid dendritic cell recruitment is a hallmark of the acute inflammatory response at mucosal surfaces. J Exp Med 1994;179:1331–1336.
Rissoan MC, Soumelis V, Kadowaki N, Grouard G, Briere F, de Waal Malefyt R, et al: Reciprocal control of T helper cell and dendritic cell differentiation. Science 1999;283:1183–1186.
Stumbles PA, Thomas JA, Pimm CL, Lee PT, Venaille TJ, Proksch S, et al: Resting respiratory tract dendritic cells preferentially stimulate T helper cell type 2 (Th2) responses and require obligatory cytokine signals for induction of Th1 immunity. J Exp Med 1998;188:2019–2031.
Akbari O, DeKruyff RH, Umetsu DT: Pulmonary dendritic cells secreting IL-10 mediate T cell tolerance induced by respiratory exposure to antigen. Nat Immunol 2001;2:725–731.
Tsitoura DC, DeKruyff RH, Lamb JR, Umetsu DT: Intranasal exposure to protein antigen induces immunological tolerance mediated by functionally disabled CD4+ T cells. J Immunol 1999;163:2592–25600.
Eisenbarth SC, Piggott DA, Huleatt JW, Visintin I, Herrick CA, Bottomly K: Lipopolysaccharide-enhanced, Toll-like receptor 4-dependent T helper cell type 2 responses to inhaled antigen. J Exp Med 2002;196:1645–1651.
Matzinger P, Guerder S: Does T-cell tolerance require a dedicated antigen-presenting cell? Nature 1989;338:74–76.
Inaba M, Inaba K, Hosono M, Kumamoto T, Ishida T, Muramatsu S, et al: Distinct mechanisms of neonatal tolerance induced by dendritic cells and thymic B cells. J Exp Med 1991;173:549–559.
Mazda O, Watanabe Y, Gyotoku J, Katsura Y: Requirement of dendritic cells and B cells in the clonal deletion of Mls-reactive T cells in the thymus. J Exp Med 1991;173:539–547.
Khoury SJ, Gallon L, Chen W, Betres K, Russell ME, Hancock WW, et al: Mechanisms of acquired thymic tolerance in experimental autoimmune encephalomyelitis: Thymic dendritic-enriched cells induce specific peripheral T cell unresponsiveness in vivo. J Exp Med 1995;182:357–366.
Viney JL, Mowat AM, O’Malley JM, Williamson E, Fanger NA: Expanding dendritic cells in vivo enhances the induction of oral tolerance. J Immunol 1998;160:5815–5825.
Dhodapkar MV, Steinman RM, Krasovsky J, Munz C, Bhardwaj N: Antigen-specific inhibition of effector T cell function in humans after injection of immature dendritic cells. J Exp Med 2001;193:233–238.
Steinman RM, Turley S, Mellman I, Inaba K: The induction of tolerance by dendritic cells that have captured apoptotic cells. J Exp Med 2000;191:411–416.
Garza KM, Chan SM, Suri R, Nguyen LT, Odermatt B, Schoenberger SP, et al: Role of antigen-presenting cells in mediating tolerance and autoimmunity. J Exp Med 2000;191:2021–2027.
Scheinecker C, McHugh R, Shevach EM, Germain RN: Constitutive presentation of a natural tissue autoantigen exclusively by dendritic cells in the draining lymph node. J Exp Med 2002;196:1079–1090.
Pugliese A, Brown D, Garza D, Murchison D, Zeller M, Redondo M, et al: Self-antigen-presenting cells expressing diabetes-associated autoantigens exist in both thymus and peripheral lymphoid organs. J Clin Invest 2001;107:555–564.
Turley SJ: Dendritic cells: Inciting and inhibiting autoimmunity. Curr Opin Immunol 2002;14:765–770.
Pugh CW, MacPherson GG, Steer HW: Characterization of nonlymphoid cells derived from rat peripheral lymph. J Exp Med 1983;157:1758–1779.
Huang FP, Platt N, Wykes M, Major JR, Powell TJ, Jenkins CD, et al: A discrete subpopulation of dendritic cells transports apoptotic intestinal epithelial cells to T cell areas of mesenteric lymph nodes. J Exp Med 2000;191:435–444.
Hemmi H, Yoshino M, Yamazaki H, Naito M, Iyoda T, Omatsu Y, et al: Skin antigens in the steady state are trafficked to regional lymph nodes by transforming growth factor-beta1-dependent cells. Int Immunol 2001;13:695–704.
Hawiger D, Inaba K, Dorsett Y, Guo M, Mahnke K, Rivera M, et al: Dendritic cells induce peripheral T cell unresponsiveness under steady state conditions in vivo. J Exp Med 2001;194:769–779.
Kurts C, Kosaka H, Carbone FR, Miller JF, Heath WR: Class I-restricted cross-presentation of exogenous self-antigens leads to deletion of autoreactive CD8(+) T cells. J Exp Med 1997;186:239–245.
Huang YM, Stoyanova N, Jin YP, Teleshova N, Hussien Y, Xiao BG, et al: Altered phenotype and function of blood dendritic cells in multiple sclerosis are modulated by IFN-beta and IL-10. Clin Exp Immunol 2001;124:306–314.
Jansen A, van Hagen M, Drexhage HA: Defective maturation and function of antigen-presenting cells in type 1 diabetes. Lancet 1995;345:491–492.
Tas M, de Haan-Meulman M, Kabel PJ, Drexhage HA: Defects in monocyte polarization and dendritic cell clustering in patients with Graves’ disease. A putative role for a non-specific immunoregulatory factor related to retroviral p15E. Clin Endocrinol (Oxf) 1991;34:441–448.
Scheinecker C, Zwolfer B, Koller M, Manner G, Smolen JS: Alterations of dendritic cells in systemic lupus erythematosus: Phenotypic and functional deficiencies. Arthritis Rheum 2001;44:856–865.
Akbari O, Freeman GJ, Meyer EH, Greenfield EA, Chang TT, Sharpe AH, et al: Antigen-specific regulatory T cells develop via the ICOS-ICOS-ligand pathway and inhibit allergen-induced airway hyperreactivity. Nat Med 2002;8:1024–1032.
Secrist H, Chelen CJ, Wen Y, Marshall JD, Umetsu DT: Allergen immunotherapy decreases interleukin 4 production in CD4+ T cells from allergic individuals. J Exp Med 1993;178:2123–2130.
Oro AS, Guarino TJ, Driver R, Steinman L, Umetsu DT: Regulation of disease susceptibility: Decreased prevalence of IgE-mediated allergic disease in patients with multiple sclerosis. J Allergy Clin Immunol 1996;97:1402–1408.
Tang L, Benjaponpitak S, DeKruyff RH, Umetsu DT: Reduced prevalence of allergic disease in patients with multiple sclerosis is associated with enhanced IL-12 production. J Allergy Clin Immunol 1998;102:428–435.
Cembrzynska-Nowak M, Szklarz E, Inglot AD, Teodorczyk-Injeyan JA: Elevated release of tumor necrosis factor-alpha and interferon-gamma by bronchoalveolar leukocytes from patients with bronchial asthma. Am Rev Respir Dis 1993;147:291–295.
Hansen G, Berry G, DeKruyff RH, Umetsu DT: Allergen-specific Th1 cells fail to counterbalance Th2 cell-induced airway hyperreactivity but cause severe airway inflammation. J Clin Invest 1999;103:175–183.
Tsitoura DC, Blumenthal RL, Berry G, DeKruyff RH, Umetsu DT: Mechanisms preventing allergen-induced airways hyperreactivity: Role of immune deviation and tolerance. J Allergy Clin Immunol 2000;106:239–246.
Romagnani S: The role of lymphocytes in allergic disease. J Allergy Clin Immunol 2000;105:399–408.
Kay AB: Role of T cells in asthma. Chem Immunol 1998;71:178–191.
Seymour BW, Gershwin LJ, Coffman RL: Aerosol-induced immunoglobulin (Ig)-E unresponsiveness to ovalbumin does not require CD8+ or T cell receptor (TCR)-gamma/delta+ T cells or interferon (IFN)-gamma in a murine model of allergen sensitization. J Exp Med 1998;187:721–731.
Platts-Mills T, Vaughan J, Squillace S, Woodfolk J, Sporik R: Sensitisation, asthma, and a modified Th2 response in children exposed to cat allergen: A population-based cross-sectional study. Lancet 2001;357:752–756.
McWilliam AS, Napoli S, Marsh AM, Pemper FL, Nelson DJ, Pimm CL, et al: Dendritic cells are recruited into the airway epithelium during the inflammatory response to a broad spectrum of stimuli. J Exp Med 1996;184:2429–2432.
Groux H, O’Garra A, Bigler M, Rouleau M, Antonenko S, de Vries JE, et al: A CD4+ T-cell subset inhibits antigen-specific T-cell responses and prevents colitis. Nature 1997;389:737–742.
Barrat FJ, Cua DJ, Boonstra A, Richards DF, Crain C, Savelkoul HF, et al: In vitro generation of interleukin 10-producing regulatory CD4(+) T cells is induced by immunosuppressive drugs and inhibited by T helper type 1 (Th1)- and Th2-inducing cytokines. J Exp Med 2002;195:603–616.
Powrie F, Carlino J, Leach MW, Mauze S, Coffman RL: A critical role for transforming growth factor-beta but not interleukin 4 in the suppression of T helper type 1-mediated colitis by CD45RB(low) CD4+ T cells. J Exp Med 1996;183:2669–26674.
Neurath MF, Fuss I, Kelsall BL, Presky DH, Waegell W, Strober W: Experimental granulomatous colitis in mice is abrogated by induction of TGF-b-mediated oral tolerance. J Exp Med 1996;183:2605–2616.
Kitani A, Fuss IJ, Nakamura K, Schwartz OM, Usui T, Strober W: Treatment of experimental (trinitrobenzene sulfonic acid) colitis by intranasal administration of transforming growth factor (TGF)-β1 plasmid: TGF-β1-mediated suppression of T helper cell type 1 response occurs by interleukin (IL)-10 induction and IL-12 receptor β2 chain downregulation. J Exp Med 2000;192:41–52.
Sakaguchi S, Sakaguchi N, Asano M, Itoh M, Toda M: Immunologic self-tolerance maintained by activated T cells expressing IL-2 receptor a-chains (CD25). J Immunol 1995;160:1151–1164.
Thornton A, Shevach EM: CD4+CD25+ immunoregulatory T cells suppress polyclonal T cell activation in vitro by inhibiting interleukin 2 production. J Exp Med 1998;188:287–296.
Jonuleit H, Schmitt E, Stassen M, Tuettenberg A, Knop J, Enk AH: Identification and functional characterization of human CD4(+)CD25(+) T cells with regulatory properties isolated from peripheral blood. J Exp Med 2001;193:1285–1294.
Sauter B, Albert ML, Francisco L, Larsson M, Somersan S, Bhardwaj N: Consequences of cell death: Exposure to necrotic tumor cells, but not primary tissue cells or apoptotic cells, induces the maturation of immunostimulatory dendritic cells. J Exp Med 2000;191:423–434.
Freeman GJ, Long AJ, Iwai Y, Bourque K, Chernova T, Nishumura H, et al: The B7-homologue, PD-L, is the ligand of the PD-1 immunoinhibitory receptor. FASEB J 2000;14:A1170.
Sharpe AH, Freeman GJ. The B7-CD28 superfamily. Nat Rev Immunol 2002;2:116–126.
Chapoval AI, Ni J, Lau JS, Wilcox RA, Flies DB, Liu D, et al: B7-H3: A costimulatory molecule for T cell activation and IFN-gamma production. Nat Immunol 2001;2:269–274.
Brocker T, Gulbranson-Judge A, Flynn S, Riedinger M, Raykundalia C, Lane P: CD4 T cell traffic control: In vivo evidence that ligation of OX40 on CD4 T cells by OX40-ligand expressed on dendritic cells leads to the accumulation of CD4 T cells in B follicles. Eur J Immunol 1999;29:1610–1616.
Ohshima Y, Tanaka Y, Tozawa H, Takahashi Y, Maliszewski C, Delespesse G: Expression and function of OX40 ligand on human dendritic cells. J Immunol 1997;159:3838–3848.
Flynn S, Toellner KM, Raykundalia C, Goodall M, Lane P: CD4 T cell cytokine differentiation: The B cell activation molecule, OX40 ligand, instructs CD4 T cells to express interleukin 4 and upregulates expression of the chemokine receptor, Blr-1. J Exp Med 1998;188:297–304.
Durkop H, Latza U, Himmelreich P, Stein H: Expression of the human OX40 (hOX40) antigen in normal and neoplastic tissues. Br J Haematol 1995;91:927–931.
Lane P: Role of OX40 signals in coordinating CD4 T cell selection, migration, and cytokine differentiation in T helper (Th)1 and Th2 cells. J Exp Med 2000;191:201–206.
Gramaglia I, Weinberg AD, Lemon M, Croft M: Ox-40 ligand: A potent costimulatory molecule for sustaining primary CD4 T cell responses. J Immunol 1998;161:6510–6517.
Bansal-Pakala P, Jember A, Croft M: Signaling through OX40 (CD134) breaks peripheral T-cell tolerance. Nat Med 2001;7:907–912.
Arestides RS, He H, Westlake RM, Chen AI, Sharpe AH, Perkins DL, et al: Costimulatory molecule OX40L is critical for both Th1 and Th2 responses in allergic inflammation. Eur J Immunol 2002;32:2874–2880.
Jember A, Zuberi R, Liu F, Croft M: Development of allergic inflammation in a murine model of asthma is dependent on the costimulatory receptor OX40. J Exp Med 2001;193:387–392.
Chen AI, McAdam AJ, Buhlmann JE, Scott S, Lupher ML Jr, Greenfield EA, et al: Ox40-ligand has a critical costimulatory role in dendritic cell:T cell interactions. Immunity 1999;11:689–698.
Akiba H, Miyahira Y, Atsuta M, Takeda K, Nohara C, Futagawa T, et al: Critical contribution of OX40 ligand to T helper cell type 2 differentiation in experimental leishmaniasis. J Exp Med 2000;191:375–380.
McAdam AJ, Greenwald RJ, Levin MA, Chernova T, Malenkovich N, Ling V, et al: ICOS is critical for CD40-mediated antibody class switching. Nature 2001;409:102–105.
Nakajima A, Watanabe N, Yoshino S, Yagita H, Okumura K, Azuma M: Requirement of CD28-CD86 co-stimulation in the interaction between antigen-primed T helper type 2 and B cells. Int Immunol 1997;9:637–644.
Mosmann TR, Coffman RL: Th1 and Th2 cells: different patterns of lymphokine secretion lead to different functional properties. Annu Rev Immunol 1989;7:145–1473.
Coffman RL, Varkila K, Scott P, Chatelain R: Role of cytokines in the differentiation of CD4+ T-cell subsets in vivo. Immunol Rev 1991;123:189–207.
Makela MJ, Kanehiro A, Borish L, Dakhama A, Loader J, Joetham A, et al: IL-10 is necessary for the expression of airway hyperresponsiveness but not pulmonary inflammation after allergic sensitization. Proc Natl Acad Sci 2000;97:6007–6012.
Levings MK, Roncarolo MG: T-regulatory 1 cells: A novel subset of CD4 T cells with immunoregulatory properties. J Allergy Clin Immunol 2000;106:S109–S112.
Akdis CA, Blesken T, Akdis M, Wuthrich B, Blaser K: Role of interleukin 10 in specific immunotherapy. J Clin Invest 1998;102:98–106.
Oh JW, Seroogy CM, Meyer EH, Akbari O, Berry G, Fathman CG, et al: CD4 T helper cells engineered to produce IL-10 reverse allergen-induced airway hyperreactivity and inflammation. J Allergy Clin Immunol 2002;110:460–468.
Hutloff A, Dittrich AM, Beier KC, Eljaschewitsch B, Kraft R, Anagnostopoulos I, et al: ICOS is an inducible T-cell co-stimulator structurally and functionally related to CD28. Nature 1999;397:263–266.
Yoshinaga SK, Whoriskey JS, Khare SD, Sarmiento U, Guo J, Horan T, et al: T-cell co-stimulation through B7RP-1 and ICOS. Nature 1999;402:827–832.
Coyle AJ, Lehar S, Lloyd C, Tian J, Delaney T, Manning S, et al: The CD28-related molecule ICOS is required for effective T cell-dependent immune responses. Immunity 2000;13:95–105.
Mages HW, Hutloff A, Heuck C, Buchner K, Himmelbauer H, Oliveri F, et al: Molecular cloning and characterization of murine ICOS and identification of B7h as ICOS ligand. Eur J Immunol 2000;30:1040–1047.
McAdam AJ, Chang TT, Lumelsky AE, Greenfield EA, Boussiotis VA, Duke-Cohan JS, et al: Mouse inducible costimulatory molecule (ICOS) expression is enhanced by CD28 costimulation and regulates differentiation of CD4+ T cells. J Immunol 2000;165:5035–5040.
Beier KC, Hutloff A, Dittrich AM, Heuck C, Rauch A, Buchner K, et al: Induction, binding specificity and function of human ICOS. Eur J Immunol 2000;30:3707–3717.
Aicher A, Hayden-Ledbetter M, Brady WA, Pezzutto A, Richter G, Magaletti D, et al: Characterization of human inducible costimulator ligand expression and function. J Immunol 2000;164:4689–4696.
Wang S, Zhu G, Chapoval AI, Dong H, Tamada K, Ni J, et al: Costimulation of T cells by B7-H2, a B7-like molecule that binds ICOS. Blood 2000;96:2808–2813.
Richter G, Hayden-Ledbetter M, Irgang M, Ledbetter JA, Westermann J, Korner I, et al: Tumor necrosis factor-alpha regulates the expression of inducible costimulator receptor ligand on CD34(+) progenitor cells during differentiation into antigen presenting cells. J Biol Chem 2001;276:45686–45693.
Ling V, Wu PW, Finnerty HF, Bean KM, Spaulding V, Fouser LA, et al: Cutting edge: Identification of GL50, a novel B7-like protein that functionally binds to ICOS receptor. J Immunol 2000;164:1653–1657.
Dong C, Juedes AE, Temann UA, Shresta S, Allison JP, Ruddle NH, et al: ICOS co-stimulatory receptor is essential for T-cell activation and function. Nature 2001;409:97–101.
Tafuri A, Shahinian A, Bladt F, Yoshinaga SK, Jordana M, Wakeham A, et al: ICOS is essential for effective T-helper-cell responses. Nature 2001;409:105–109.
Tesciuba AG, Subudhi S, Rother RP, Faas SJ, Frantz AM, Elliot D, et al: Inducible costimulator regulates Th2-mediated inflammation, but not Th2 differentiation, in a model of allergic airway disease. J Immunol 2001;167:1996–2003.
Swallow MM, Wallin JJ, Sha WC: B7h, a novel costimulatory homolog of B7.1 and B7.2, is induced by TNFalpha. Immunity 1999;11:423–432.
Gonzalo JA, Tian J, Delaney T, Corcoran J, Rottman JB, Lora J, et al: ICOS is critical for T helper cell-mediated lung mucosal inflammatory responses. Nat Immunol 2001;2:597–604.
Sporici RA, Beswick RL, von Allmen C, Rumbley CA, Hayden-Ledbetter M, Ledbetter JA, et al: ICOS ligand costimulation is required for T-cell encephalitogenicity. Clin Immunol 2001;100:277–288.
Segal BM, Dwyer BK, Shevach EM: An interleukin (IL)-10/IL-12 immunoregulatory circuit controls susceptibility to autoimmune disease. J Exp Med 1998;187:537–546.
Bettelli E, Das MP, Howard ED, Weiner HL, Sobel RA, Kuchroo VK: IL-10 is critical in the regulation of autoimmune encephalomyelitis as demonstrated by studies of IL-10- and IL-4-deficient and transgenic mice. J Immunol 1998;161:3299–3306.
Rottman JB, Smith T, Tonra JR, Ganley K, Bloom T, Silva R, et al: The costimulatory molecule ICOS plays an important role in the immunopathogenesis of EAE. Nat Immunol 2001;2:605–611.
Umetsu DT, DeKruyff RH: Th1 and Th2 CD4+ cells in human allergic diseases. J Aller Clin Immunol 1997;100:1–6.
Umetsu D, McIntire J, Macaubas C, Akbari O, DeKruyff R: Asthma: An epidemic of dysregulated immunity. Nat Immunol 2002;3:715–720.
Wannemuehler MJ, Kiyono H, Babb JL, Michalek SM, McGhee JR: Lipopolysaccharide (LPS) regulation of the immune response: LPS converts germfree mice to sensitivity to oral tolerance induction. J Immunol 1982;129:959–965.
Sudo N, Sawamura S, Tanaka K, Aiba Y, Kubo C, Koga Y: The requirement of intestinal bacterial flora for the development of an IgE production system fully susceptible to oral tolerance induction. J Immunol 1997;159:1739–1745.
Ogura Y, Inohara N, Benito A, Chen F, Yamaoka S, Nunez G: Nod2, a Nod1/Apaf-1 family member that is restricted to monocytes and activates NF-kappaB. J Biol Chem 2001;276:4812–4818.
Ogura Y, Bonen DK, Inohara N, Nicolae DL, Chen FF, Ramos R, et al: A frameshift mutation in NOD2 associated with susceptibility to Crohn’s disease. Nature 2001;411:603–606.
Hugot JP, Chamaillard M, Zouali H, Lesage S, Cezard JP, Belaiche J, et al: Association of NOD2 leucine-rich repeat variants with susceptibility to Crohn’s disease. Nature 2001;411:599–603.
Neish AS, Gewirtz AT, Zeng H, Young AN, Hobert ME, Karmali V, et al: Prokaryotic regulation of epithelial responses by inhibition of IkappaB-alpha ubiquitination. Science 2000;289:1560–1563.
Mahanty S, Mollis SN, Ravichandran M, Abrams J, Kumaraswami V, Jayaraman K, et al: High levels of spontaneous and parasite antigen-driven interleukin-10 production are associated with antigen-specific hyporesponsiveness in human lymphatic filariasis. J Infect Dis 1996;173:769–773.
Yazdanbakhsh M, Kremsner PG, van Ree R: Allergy, parasites, and the hygiene hypothesis. Science 2002;296:490–494.
Diez-Gonzalez F, Callaway TR, Kizoulis MG, Russell JB: Grain feeding and the dissemination of acid-resistant Escherichia coli from cattle. Science 1998;281:1666–1668.
Tsitoura DC, Kim S, Dabbagh K, Berry G, Lewis DB, Umetsu DT: Respiratory infection with influenza A virus interferes with the induction of tolerance to aeroallergens. J Immunol 2000;165:3484–3491.
© 2003 S. Karger AG, Basel
2003
Copyright / Drug Dosage / Disclaimer
Copyright: All rights reserved. No part of this publication may be translated into other languages, reproduced or utilized in any form or by any means, electronic or mechanical, including photocopying, recording, microcopying, or by any information storage and retrieval system, without permission in writing from the publisher.
Drug Dosage: The authors and the publisher have exerted every effort to ensure that drug selection and dosage set forth in this text are in accord with current recommendations and practice at the time of publication. However, in view of ongoing research, changes in government regulations, and the constant flow of information relating to drug therapy and drug reactions, the reader is urged to check the package insert for each drug for any changes in indications and dosage and for added warnings and precautions. This is particularly important when the recommended agent is a new and/or infrequently employed drug.
Disclaimer: The statements, opinions and data contained in this publication are solely those of the individual authors and contributors and not of the publishers and the editor(s). The appearance of advertisements or/and product references in the publication is not a warranty, endorsement, or approval of the products or services advertised or of their effectiveness, quality or safety. The publisher and the editor(s) disclaim responsibility for any injury to persons or property resulting from any ideas, methods, instructions or products referred to in the content or advertisements.
You do not currently have access to this content.
Sign in
Digital Version
Pay-Per-View Access
$39.00
1 Karger Article Bundle Token
$150
Rental
This article is also available for rental through DeepDyve. 